Income Taxes (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
Income Taxes [Line Items] | ||
Valuation allowance | $ 47,011,175 | $ 35,566,934 |
Federal net operating loss carryforwards | 109,644,085 | |
Benefits of tax | 23,025,258 | |
State net operating loss carryforwards | 72,622,999 | |
Deferred Tax Assets, Net | 4,984,749 | |
Net operating loss | 28,276,145 | |
Future tax | $ 7,069,870 | |
Uncertain tax | 30.00% | |
Description of operating loss carryovers, limitations of use | IRC Section 382 imposes limitations on the use of net operating loss carryovers when the stock ownership of one or more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis by more than 50 percentage points. As of December 31, 2024, the Company has not completed an analysis on the 382 limitation. A 382 limitation calculation will be considered prior to the usage of tax attributes. | |
Research expenses | $ 6,818,064 | 6,406,470 |
Research Tax Credit Carryforward [Member] | ||
Income Taxes [Line Items] | ||
Research expenses | $ 6,114,653 | |
Federal Jurisdiction [Member] | Research Tax Credit Carryforward [Member] | ||
Income Taxes [Line Items] | ||
Credit carryforwards | $ 4,092,749 |